Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Liu Chen

Showing results (61-70 of 563) with videos related to

Pageof 57
Sort By:
Molecular Pharmacology|October 20, 2001
Inverse agonist up-regulates the constitutively active D3.49(164)Q mutant of the rat mu-opioid receptor by stabilizing the structure and blocking constitutive internalization and down-regulationJ Li, C Chen, P Huang, et al.
Micromachines|September 27, 2025
Material Removal on Hydrogen-Terminated Diamond Surface via AFM Tip-Based Local Anodic OxidationJinyan Tang, Zhong-Hao Cao, Zhongwei Li, et al.
The Review of Scientific Instruments|March 2, 2022
3D printing of multi-metallic microstructures by meniscus-confined electrodepositionYutao Wang, Xin Xiong, Bing-Feng Ju, et al.
Biochemistry|October 3, 2002
The local environment at the cytoplasmic end of TM6 of the mu opioid receptor differs from those of rhodopsin and monoamine receptors: introduction of an ionic lock between the cytoplasmic ends of helices 3 and 6 by a L6.30(275)E mutation inactivates the mu opioid receptor and reduces the constitutive activity of its T6.34(279)K mutantPeng Huang, Irache Visiers, Harel Weinstein, et al.
European Journal of Pharmacology|June 10, 2015
Intrinsic relative activities of κ opioid agonists in activating Gα proteins and internalizing receptor: Differences between human and mouse receptorsKelly M DiMattio, Frederick J Ehlert, Lee-Yuan Liu-Chen
The Journal of Pharmacology and Experimental Therapeutics|August 3, 2006
Ligands regulate cell surface level of the human kappa opioid receptor by activation-induced down-regulation and pharmacological chaperone-mediated enhancement: differential effects of nonpeptide and peptide agonistsYong Chen, Chongguang Chen, Yulin Wang, et al.
Molecular Pharmacology|September 22, 2000
Mechanisms of agonist-induced down-regulation of the human kappa-opioid receptor: internalization is required for down-regulationJ G Li, J L Benovic, L Y Liu-Chen
The Journal of Biological Chemistry|March 11, 2011
Effects of C-terminal modifications of GEC1 protein and gamma-aminobutyric acid type A (GABA(A)) receptor-associated protein (GABARAP), two microtubule-associated proteins, on kappa opioid receptor expressionChongguang Chen, Yulin Wang, Peng Huang, et al.
FEBS Letters|January 7, 1999
Palmitoylation of the rat mu opioid receptorC Chen, V Shahabi, W Xu, et al.
ACS Omega|September 9, 2024
Recent Progress on In Situ Catalytic Conversion Catalysts for Oil ShaleAibin Wu, Junwen Wu, Liu Chen, et al.
Pageof 57

Showing results (61-70 of 563) with videos related to

Sort By:
Pageof 57
Molecular Pharmacology|October 20, 2001
Inverse agonist up-regulates the constitutively active D3.49(164)Q mutant of the rat mu-opioid receptor by stabilizing the structure and blocking constitutive internalization and down-regulationJ Li, C Chen, P Huang, et al.
Micromachines|September 27, 2025
Material Removal on Hydrogen-Terminated Diamond Surface via AFM Tip-Based Local Anodic OxidationJinyan Tang, Zhong-Hao Cao, Zhongwei Li, et al.
The Review of Scientific Instruments|March 2, 2022
3D printing of multi-metallic microstructures by meniscus-confined electrodepositionYutao Wang, Xin Xiong, Bing-Feng Ju, et al.
Biochemistry|October 3, 2002
The local environment at the cytoplasmic end of TM6 of the mu opioid receptor differs from those of rhodopsin and monoamine receptors: introduction of an ionic lock between the cytoplasmic ends of helices 3 and 6 by a L6.30(275)E mutation inactivates the mu opioid receptor and reduces the constitutive activity of its T6.34(279)K mutantPeng Huang, Irache Visiers, Harel Weinstein, et al.
European Journal of Pharmacology|June 10, 2015
Intrinsic relative activities of κ opioid agonists in activating Gα proteins and internalizing receptor: Differences between human and mouse receptorsKelly M DiMattio, Frederick J Ehlert, Lee-Yuan Liu-Chen
The Journal of Pharmacology and Experimental Therapeutics|August 3, 2006
Ligands regulate cell surface level of the human kappa opioid receptor by activation-induced down-regulation and pharmacological chaperone-mediated enhancement: differential effects of nonpeptide and peptide agonistsYong Chen, Chongguang Chen, Yulin Wang, et al.
Molecular Pharmacology|September 22, 2000
Mechanisms of agonist-induced down-regulation of the human kappa-opioid receptor: internalization is required for down-regulationJ G Li, J L Benovic, L Y Liu-Chen
The Journal of Biological Chemistry|March 11, 2011
Effects of C-terminal modifications of GEC1 protein and gamma-aminobutyric acid type A (GABA(A)) receptor-associated protein (GABARAP), two microtubule-associated proteins, on kappa opioid receptor expressionChongguang Chen, Yulin Wang, Peng Huang, et al.
FEBS Letters|January 7, 1999
Palmitoylation of the rat mu opioid receptorC Chen, V Shahabi, W Xu, et al.
ACS Omega|September 9, 2024
Recent Progress on In Situ Catalytic Conversion Catalysts for Oil ShaleAibin Wu, Junwen Wu, Liu Chen, et al.
Pageof 57